Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Equity Income (2019 - 2024)

Viemed Healthcare (VMD) has disclosed Equity Income for 5 consecutive years, with $96000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Equity Income fell 64.44% year-over-year to $96000.0, compared with a TTM value of $96000.0 through Jun 2025, up 113.03%, and an annual FY2024 reading of -$954000.0, down 296.7% over the prior year.
  • Equity Income was $96000.0 for Q3 2024 at Viemed Healthcare, up from -$1.1 million in the prior quarter.
  • Across five years, Equity Income topped out at $459000.0 in Q4 2021 and bottomed at -$1.1 million in Q2 2024.
  • Average Equity Income over 5 years is $94631.6, with a median of $84000.0 recorded in 2022.
  • The sharpest move saw Equity Income skyrocketed 1476.19% in 2021, then tumbled 915.33% in 2024.
  • Year by year, Equity Income stood at $55000.0 in 2020, then skyrocketed by 734.55% to $459000.0 in 2021, then crashed by 82.14% to $82000.0 in 2022, then tumbled by 47.56% to $43000.0 in 2023, then surged by 123.26% to $96000.0 in 2024.
  • Business Quant data shows Equity Income for VMD at $96000.0 in Q3 2024, -$1.1 million in Q2 2024, and $67000.0 in Q1 2024.